BKV Corp (NYSE: BKV) CEO 10b5-1 sale of 100,000 shares

Rhea-AI Filing Summary

BKV Corp Chief Executive Officer Christopher P. Kalnin reported an open-market sale of 100,000 shares of common stock at a weighted average price of $30.0579 per share. The sale was executed under a Rule 10b5-1 trading plan adopted on December 8, 2025.

After this transaction, he directly holds 1,197,243 shares and has an additional 875,754 shares reported as indirectly owned through his spouse.

Insider Trade Summary 10b5-1

Net Seller: 100,000 shares ($3,005,790)

Net Sell 2 txns

Insider Kalnin Christopher P

Role Chief Executive Officer

Sold 100,000 shs ($3.01M)

Type	Security	Shares	Price	Value
Sale	Common Stock	100,000	$30.0579	$3.01M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,197,243 shares (Direct); Common Stock — 875,754 shares (Indirect, By Spouse)

Footnotes (1)

1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2025. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kalnin Christopher P

(Last) (First) (Middle)

1200 17TH STREET, SUITE 2100

(Street)

DENVER COLORADO 80202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BKV Corp [ BKV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/25/2026		S(1)		100,000	D	$30.0579(2)	1,197,243	D
Common Stock								875,754	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2025.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Kathleen Lenox, attorney-in-fact	03/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

How many BKV (BKV) shares did the CEO sell in this Form 4?

The CEO, Christopher P. Kalnin, sold 100,000 shares of BKV common stock. The transaction was reported as an open-market sale at a weighted average price of $30.0579 per share, according to the Form 4 filing details.

At what price were the BKV (BKV) shares sold by the CEO?

The reported weighted average sale price was $30.0579 per share. Footnotes state the shares were sold in multiple transactions at prices ranging from $30.00 to $30.14, and detailed price breakdowns are available on request from the reporting person.

Was the BKV (BKV) CEO’s share sale under a Rule 10b5-1 plan?

Yes. The Form 4 notes the transaction was effected under a Rule 10b5-1 trading plan. The plan was adopted by CEO Christopher P. Kalnin on December 8, 2025, indicating the sale was pre-arranged rather than an ad hoc market decision.

How many BKV (BKV) shares does the CEO hold after this transaction?

Following the sale, Christopher P. Kalnin directly holds 1,197,243 shares of BKV common stock. The filing also reports an additional 875,754 shares as indirectly owned through his spouse, reflecting his total reported post-transaction equity exposure.

Does this BKV (BKV) Form 4 include any option exercises or derivative trades?

No derivative transactions are reported in this Form 4. The filing shows one open-market sale of 100,000 shares of common stock and an indirect holding entry for shares owned by the CEO’s spouse, with no listed option exercises or conversions.

What indirect BKV (BKV) holdings are reported for the CEO in this Form 4?

The Form 4 reports 875,754 shares of BKV common stock as indirectly owned “By Spouse.” This indirect holding is classified as an ownership entry, not a new transaction, and is separate from the CEO’s directly held 1,197,243 shares.